ROCKVILLE, Md. (WJZ) — The U.S. Food and Drug Administration has approved a Maryland company’s potential HIV cure for human trials, the company announced this week.

Rockville-based American Gene Technologies said in a news release it will begin its phase one study at sites in the Baltimore and Washington, D.C. areas.

READ MORE: B&O Railroad Museum Offering Free Admission To Active Duty Military Personnel Through Labor Day

READ MORE: Maryland Medical Company Claims To Have Cure For HIV, AIDS

READ MORE: More Baby Formula Is Heading To Store Shelves As Early As This Weekend

In November 2019, the company said its single-dose gene therapy has a “high potential” of being effective, describing the treatment as a genetically-modified product made from a person’s own cells that focuses on repairing immune system damage caused by the virus.

MORE NEWS: Here's How To Travel Safely And Efficiently On Memorial Day Weekend

The trial is set to begin next month, and the company hopes to report initial data by the end of 2020.

CBS Baltimore Staff